← Eichor
Condition: Hepatic Portal Vein Tumor Invasion Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hepatic Portal Vein Tumor Invasion

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

TACE Plus Atezolizumab/Bevacizumab and I-125 Seeds Brachytherapy for HCC With Branch PVTT
NA · 1 location(s) · Third Affiliated Hospital, Sun Yat-Sen University · NCT05984511Atezolizumab Plus Bevacizumab Alone or Combined with External Beam Radiotherapy for HCC with Macrovascular Invasion
Phase 2 · 1 location(s) · Asan Medical Center · NCT05992220
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.